[Immunotherapeutic effects of beta-elemene combined with interleukin-23 gene-modified dendritic cells on murine pancreatic carcinoma]
/in International Publications, Pancreatic Cancer /von 2006-09-01 / Ai Zheng 2006 Sep;25(9):1082-6Immunesurveillance by dendritic cells: potential implication for immunotherapy of endocrine cancers
/in Dendritic Cells, International Publications, Thyroid Cancer /von 2006-09-01 / Endocr. Relat. Cancer 2006 Sep;13(3):779-95Successful immunological treatment of gallbladder cancer in India–case report
/in Gallbladder Cancer, International Publications /von 2006-09-01 / J Zhejiang Univ Sci B 2006 Sep;7(9):719-24Apoptotic, necrotic, or fused tumor cells: an equivalent source of antigen for dendritic cell loading
/in Colorectal Cancer, International Publications /von 2006-09-01 / Apoptosis 2006 Sep;11(9):1513-24Dendritic cell-based immunotherapy
/in Dendritic Cells, International Publications /von 2006-09-01 / Int. Rev. Immunol. 2006 Sep-Dec;25(5-6):377-413Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells
/in Glioblastoma, International Publications /von 2006-09-01 / Cancer Res. 2006 Sep;66(17):8887-96Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity
/in International Publications, Malignant Melanoma /von 2006-09-01 / J. Immunother. 2006 Sep-Oct;29(5):545-57Improved overall survival in dendritic cell vaccination-induced immunoreactive subgroup of advanced melanoma patients
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2006-08-16 / J Transl Med 2006 Aug;4:36Targeting the heat shock factor 1 by RNA interference: a potent tool to enhance hyperthermochemotherapy efficacy in cervical cancer
/in Cervical Cancer, International Publications /von 2006-08-01 / Cancer Res. 2006 Aug;66(15):7678-85
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution